FDA Adds Kidney Injury Warning to OTC Weight-Loss Drug Orlistat
The US Food and Drug Administration (FDA) approved labeling changes for the over-the-counter (OTC) weight-loss drug orlistat to warn of acute kidney injury risks.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.